Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.66 |
| ▸ | CA1 | P00915 | 1/20 | 0.66 |
| ▸ | CA2 | P00918 | 1/20 | 0.66 |
| ▸ | CA7 | P43166 | 1/20 | 0.66 |
| ▸ | CA9 | Q16790 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | NQO1 | P15559 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 3/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11087708 | 0.98 | CA12 (0.63) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL11519194 | 0.98 | CA12 (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6278422 | 0.94 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| Methylene Chloride SCHEMBL28109052 | 0.93 | CA12 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10412880 | 0.91 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8876368 | 0.87 | CA12 (0.51) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4527668 | 0.84 | CA12 (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16376096 | 0.84 | CA12 (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3494901 | 0.84 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6367290 | 0.83 | MMP3 (0.51) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1847568-B1 | THERMOSETTING RESIN COMPOSITION, THERMOSETTING-RESIN MOLDING MATERIAL, AND CURED OBJECT OBTAINED THEREFROM | SUMITOMO BAKELITE CO (JP) | 2015-05-20 | — | — | EP | claimed |
| CN-101065445-B | Thermosetting resin composition, thermosetting-resin molding material, and cured object obtained therefrom | SUMITOMO BAKELITE CO | 2011-05-11 | — | — | CN | claimed |
| US-7541410-B2 | Thermosetting resin composition, thermosetting resin molding compound and cured product thereof | SUMITOMO BAKELITE CO., LTD. (JP) | 2009-06-02 | — | — | US | claimed |
| US-20080139757-A1 | Thermosetting Resin Composition, Thermosetting Resin Molding Compound And Cured Product Thereof | SUMITOMO BAKELITE CO., LTD. (JP) | 2008-06-12 | — | — | US | claimed |
| US-5854299-A | Process for the polymerization of cyclic olefins and polymerizable composition | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-12-29 | — | — | US | claimed |
| EP-0722468-A1 | PROCESS FOR THE POLYMERIZATION OF CYCLIC OLEFINS AND A POLYMERIZABLE COMPOSITION | Ciba SC Holding AG (CH) | 1996-07-24 | — | — | EP | claimed |
| WO-1995007310-A1 | PROCESS FOR THE POLYMERIZATION OF CYCLIC OLEFINS AND A POLYMERIZABLE COMPOSITION | CIBA-GEIGY AG (CH) | 1995-03-16 | — | — | WO | claimed |
| CN-113968949-B | High-adaptability water reducer based on biological amino acid, and preparation method and application thereof | 博特新材料泰州有限公司 | 2023-11-07 | — | — | CN | disclosed |
| US-20220069354-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2022-03-03 | — | — | US | disclosed |
| CN-113968949-A | High-adaptability water reducing agent based on biological amino acid and preparation method and application thereof | 博特新材料泰州有限公司 | 2022-01-25 | — | — | CN | disclosed |
| EP-3904337-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | FUJIFILM Wako Pure Chemical Corporation (JP) | 2021-11-03 | — | — | EP | disclosed |
| EP-3406645-B1 | EPOXY RESIN COMPOSITION | NEW JAPAN CHEM CO LTD (JP) | 2020-09-30 | — | — | EP | disclosed |
| EP-2647667-B1 | CURABLE EPOXY RESIN COMPOSITION | DAICEL CORP (JP) | 2019-09-25 | — | — | EP | disclosed |
| WO-1996023829-A1 | POLYMERISABLE COMPOSITION, PROCESS FOR PRODUCING CROSS-LINKED POLYMERS, AND CROSS-LINKABLE POLYMERS | CIBA SPECIALTY CHEMICALS INC. (CH) | 1996-08-08 | — | — | WO | disclosed |
| EP-0722468-A1 | PROCESS FOR THE POLYMERIZATION OF CYCLIC OLEFINS AND A POLYMERIZABLE COMPOSITION | Ciba SC Holding AG (CH) | 1996-07-24 | — | — | EP | disclosed |
| WO-1996020235-A1 | POLYMERISABLE COMPOUND AND A POLYMERISATION PROCESS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1996-07-04 | — | — | WO | disclosed |
| WO-1996016100-A1 | THERMAL METATHESIS POLYMERISATION PROCESS AND A POLYMERISABLE COMPOSITION | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1996-05-30 | — | — | WO | disclosed |
| WO-1995007310-A1 | PROCESS FOR THE POLYMERIZATION OF CYCLIC OLEFINS AND A POLYMERIZABLE COMPOSITION | CIBA-GEIGY AG (CH) | 1995-03-16 | — | — | WO | disclosed |
| US-4489091-A | ESTERASE AND ANTIBODY INHIBITORS | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1984-12-18 | — | — | US | disclosed |
| US-4411911-A | Method of treating hyperlipidemia and inflammation with sulfonate derivatives | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1983-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220069354-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | SLC26A3, PRDX4, PRDX2 | CA12 204/4885CA1 22/4885CA2 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.